Pfizer-BioNTech agree to supply COVID-19 vaccines to COVAX alliance
Details on the size of the deal or the price per dose COVAX would pay were not immediately clear, but the sources said the allotment would likely be relatively small
Reuters | January 22, 2021 | Updated 09:06 IST
The COVAX scheme is set to start distributing Covid-19 vaccines to poor and middle income countries in February
Pfizer and BioNTech have agreed to supply their Covid-19 vaccine to the World Health Organization co-led COVAX vaccine access scheme, two sources familiar with the deal said, the latest in a series of shots to be included in the project aimed at lower-income countries.
Coronavirus Vaccine Updates: India to distribute COVID-19 vaccines to its neighbours, except Pakistan
COVID-19 vaccines: Many countries are negotiating at the government level while many have placed the orders directly to vaccine manufactures.
Publish Date: Tue, 12 Jan 2021 11:49 AM IST
file pic
New Delhi| Jagran News Desk: COVID-19 has been one of the most deadly viruses that took millions of lives across the world. However, now India seems to put a full stop on the outspread of coronavirus with the help of COVID-19 vaccine.
India has been a leader in supplying drugs across the globe and now the country is all set to distribute COVID-19 vaccine to fight the pandemic. India is going to adopt the HCQ model to give other neighbouring countries access to the vaccines being manufactured in the country. Apart from neighbouring countries Japan, South Africa, Brazil and Australia have also approached India regarding the vaccines.